Feb 05, 2018 21:01 pm UTC| Business
NESS ZIONA, Israel, Feb. 05, 2018 -- Sol-Gel Technologies Ltd. (“Sol-Gel”) (NASDAQ:SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug...
Feb 05, 2018 21:01 pm UTC| Business
Comprehensive Study Includes All Danish Women Diagnosed with Breast Cancer from 2000 to 2003 who were Indicated for Prosigna and Treated with Endocrine Therapy Accompanying Editorial Highlights Encouraging Data on...
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Feb 05, 2018 21:01 pm UTC| Business
MALVERN, Pa., Feb. 05, 2018 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to...
Bio-Path Holdings to Present at the BIO CEO & Investor Conference
Feb 05, 2018 21:01 pm UTC| Business
HOUSTON, Feb. 05, 2018 -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid...
Feb 05, 2018 21:01 pm UTC| Business
PLANO, Texas, Feb. 05, 2018 -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today the closing of its underwritten follow-on public offering of 3,248,750 shares of its common...
GW Pharmaceuticals plc Reports Fiscal First Quarter 2018 Financial Results and Operational Progress
Feb 05, 2018 21:00 pm UTC| Business
- Epidiolex® (cannabidiol) NDA and MAA applications accepted for review –- NDA PDUFA goal date scheduled for June 27, 2018 -- Conference call today at 4:30 p.m. EST - LONDON and CARLSBAD, Calif., Feb. 05, 2018 -- GW...
Feb 05, 2018 21:00 pm UTC| Business
HERNDON, Va., Feb. 05, 2018 -- Command Security Corporation (NYSE MKT:MOC) today reported its financial results for its third fiscal quarter ended December 31, 2017. Highlights for the quarter include the following: ...